Medherant raises £3.8 million in latest funding round

Medherant — a company focused on transdermal drug delivery — has revealed that it has raised £3.8 million in its latest funding round, which will support the company as it progresses its ibuprofen TEPI Patch into clinical development early next year more

12 Dec 2017 12:03 News